SonoThera Closes Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Ultrasound-Mediated Nonviral Genetic Medicines. Learn more.

Delivering Large Genetic Payloads With SonoThera’s Ken Greenberg

July 29, 2026

Inquiries about our Clinical Research

Contact Us